|
000
| 02187cam 2200313za 4500 |
|---|
| 001 | 9.833905 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107150322 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 170320s2016 oncd os f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 041 | 0 |aeng|afre |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH82-22/2016-PDF |
|---|
| 245 | 00|aPrivate drug plans in Canada |h[electronic resource] : |bcost drivers, 2008 to 2015 = Les facteurs de coût des régimes privés d’assurance-médicaments au Canada, de 2008 à 2015. |
|---|
| 246 | 31|aFacteurs de coût des régimes privés d’assurance-médicaments au Canada, de 2008 à 2015 |
|---|
| 260 | |a[Ottawa] : |bPatented Medicine Prices Review Board, |c[2016] |
|---|
| 300 | |a[1] p. : |bcol. charts |
|---|
| 500 | |aCaption title. |
|---|
| 500 | |aAt head of title: National Prescription Drug Utilization Information System. |
|---|
| 520 | |a"After a few years of slow growth, there has been an increasingly upward pressure on prescription drug spending in Canada. This report analyzes the recent trends in expenditures from the perspective of Canadian private drug plans, with a focus on drug costs in 2015. It explores the drivers of change, identifying the most important cost pressures and measuring their impact on expenditure levels. This study complements the annual PMPRB CompassRx report, which provides a similar analysis of the public drug plan environment. This is one of three reports in a PMPRB series that analyzes the trends in Canadian private drug plans. This series provides policy makers and other stakeholders with valuable insights into the sources of cost pressures in private drug plans and supports them in predicting future trends and identifying cost-saving opportunities." |
|---|
| 546 | |aText in English and French. |
|---|
| 692 | 07|2gccst|aDrug insurance |
|---|
| 692 | 07|2gccst|aPrescription drugs |
|---|
| 692 | 07|2gccst|aPrices |
|---|
| 710 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 710 | 2 |aNational Prescription Drug Utilization Information System (Canada) |
|---|
| 792 | |tPrivate drug plans in Canada |w(CaOODSP)9.833911 |
|---|
| 856 | 40|qPDF|s386 KB|uhttps://publications.gc.ca/collections/collection_2017/cepmb-pmprb/H82-22-2016.pdf |
|---|